European Journal of Therapeutics, cilt.27, sa.4, ss.311-317, 2021 (ESCI)
Objective: We aimed to evaluate the degree of QTc prolongation and associated factors in patients with COVID-19 in association with their usage of hydroxychloroquine (HCQ) with or without the combination of azithromycin (AZ) and/or favipiravir (FAV).